These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 2410531)

  • 1. Expression of murine Lm-1 locus. Lm-1 determinants on lymphocytes and macrophages, and effects of Lm-1 incompatibility on bone marrow grafts.
    O'Toole MM; Bosma GC; Bosma MJ
    J Exp Med; 1985 Aug; 162(2):607-24. PubMed ID: 2410531
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification and mapping of Lm-1, an Igh-linked locus for a murine alloantigen.
    O'Toole MM; Riblet R; Bosma MJ
    Immunogenetics; 1984; 20(3):265-75. PubMed ID: 6332069
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Two monoclonal antibodies defining unique antigenic determinants on human B-lymphoma cells.
    Howard DR; Eaves AC; Takei F
    Cancer Res; 1985 Dec; 45(12 Pt 1):6322-7. PubMed ID: 2415242
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fidelity and infidelity in commitment to B-lymphocyte lineage development.
    Rolink AG; Schaniel C; Busslinger M; Nutt SL; Melchers F
    Immunol Rev; 2000 Jun; 175():104-11. PubMed ID: 10933595
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell surface antigens expressed by subsets of pre-B cells and B cells.
    McKearn JP; Baum C; Davie JM
    J Immunol; 1984 Jan; 132(1):332-9. PubMed ID: 6606670
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term immunologic tolerance induction in chimeric mice after bone marrow transplantation across major histocompatibility barriers: persistent or redeveloping immunologic responsiveness after prolonged survival.
    Sugiura K; Yasumizu R; Iwai H; Inaba MM; Toki J; Ogura M; Hara I; Good RA; Ikehara S
    Thymus; 1991 Nov; 18(3):137-53. PubMed ID: 1838450
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lym 7.2: monoclonal antibody defining an alloantigen similar or identical to Ly 7.2.
    Lanier LL; Warner NL
    Hybridoma; 1982; 1(3):227-41. PubMed ID: 6208126
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Collaboration of histoincompatible T and B lymphocytes using cells from tetraparental bone marrow chimeras.
    von Boehmer H; Hudson L; Sprent J
    J Exp Med; 1975 Oct; 142(4):989-97. PubMed ID: 51901
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thymocytes from mice immunized against an allograft render bone-marrow cells specifically cytotoxic.
    Grant CK; Currie GA; Alexander P
    J Exp Med; 1972 Jan; 135(1):150-64. PubMed ID: 5009704
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hybrid resistance to EL-4 lymphoma cells. I. Characterization of natural killer cells that lyse EL-4 cells and their distinction from marrow-dependent natural killer cells.
    Kumar V; Luevano E; Bennett M
    J Exp Med; 1979 Sep; 150(3):531-47. PubMed ID: 383877
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Critical role of determinant presentation in the induction of specific responses in immunocompetent lymphocytes.
    Katz DH; Unanue ER
    J Exp Med; 1973 Apr; 137(4):967-90. PubMed ID: 4120897
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A new lymphocyte alloantigen (Ly-10) controlled by a gene linked to the Lyt-1 locus.
    Kimura S; Tada N; Hämmerling U
    Immunogenetics; 1980; 10(4):363-72. PubMed ID: 22457928
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of T and B lymphocytes in vitro. III. Presence of Ia determinants on allogeneic effect factor.
    Armerding D; Sachs DH; Katz DH
    J Exp Med; 1974 Dec; 140(6):1717-22. PubMed ID: 4139236
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The target minor H antigen for F1 cytotoxic T lymphocytes induced by Igh-congenic parental spleen cells is coded for by gene linked to H-2.
    Ishikawa H; Kubota E; Suzuki H; Saito K
    J Immunol; 1985 May; 134(5):2953-9. PubMed ID: 2580009
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Graft-facilitating doses of ex vivo activated gammadelta T cells do not cause lethal murine graft-vs.-host disease.
    Drobyski WR; Majewski D; Hanson G
    Biol Blood Marrow Transplant; 1999; 5(4):222-30. PubMed ID: 10465102
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mouse alloantigen system Ly-m22 predominantly expressed on T lymphocytes and controlled by a gene linked to M1s region on chromosome 1.
    Tada N; Kimura S; Liu-Lam Y; Hammerling U
    Hybridoma; 1983; 2(1):29-38. PubMed ID: 6332054
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Abrogation of bone marrow allograft resistance in mice by increased total body irradiation correlates with eradication of host clonable T cells and alloreactive cytotoxic precursors.
    Schwartz E; Lapidot T; Gozes D; Singer TS; Reisner Y
    J Immunol; 1987 Jan; 138(2):460-5. PubMed ID: 3098843
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence for identity or close association of the Fc receptor of B lymphocytes and alloantigens determined by the Ir region of the H-2 complex.
    Dickler HB; Sachs DH
    J Exp Med; 1974 Sep; 140(3):779-96. PubMed ID: 4137653
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peculiar immunobiology of bone marrow allografts. II. Rejection of parental grafts by resistant F 1 hybrid mice.
    Cudkowicz G; Bennett M
    J Exp Med; 1971 Dec; 134(6):1513-28. PubMed ID: 4942407
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell-mediated lympholysis of trinitrophenyl-modified autologous lymphocytes. Effector cell specificity to modified cell surface components controlled by H-2K and H-2D serological regions of the murine major histocompatibility complex.
    Shearer GM; Rehn TG; Garbarino CA
    J Exp Med; 1975 Jun; 141(6):1348-64. PubMed ID: 47900
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.